Company Profile

Olainfarm AS is a Latvia-based company engaged in the pharmaceutical sector. The Company is active in the production of basic pharmaceutical products and pharmaceutical preparations. The Company's activities include numerous finished forms of medicaments with effects, which include cardiological, neurologic, diuretic, spasmologic and antiallergic drug preparations, medicaments treating the digestive system, antibiotics and food supplements, as well as various active chemical ingredients and raw chemical materials. Its products include Amlodipine, Clonazepam, Euphillin, Furosemide, Furagin, Midolat, Protionol and Gripoflex, among others. The Company operates through its subsidiaries which includes Reinolds SIA, Ozols JDR SIA, Olainfarm energija SIA, Ilmas Aptiekas SIA and Veritas-Farm, among others. In addition, the Company has 33 pharmacies, located in Riga, Vidzeme, Kurzeme and Latgale. In May 2013, it acquired a 47.5% shares in pharmaceutical manufacturer SIA Silvanols.

Employees

2,191

Sector

Pharmaceuticals

More about the company

07/12/21	AS "AB CITY" completed the acquisition of an additional 49.19% stake in AS Olainfarm from a group of shareholders for €64.2 million.	CI
12/11/21	Olainfarm Board OKs AB City's Mandatory Share Buyback Offer	MT
30/09/21	AS Olainfarm : AB City Plans to Initiate Mandatory Repurchase Offer for Olainfarm Shares	MT
30/09/21	AS "AB CITY" made an offer to acquire an additional 50.8% stake in AS Olainfarm from a group of shareholders for €66.3 million.	CI
31/08/21	AS Olainfarm, Q2 2021 Earnings Call, Aug 31, 2021
31/08/21	As Olainfarm Reports Earnings Results for the Half Year Ended June 30, 2021	CI
25/08/21	AS "AB CITY" completed the acquisition of 48.08% stake in AS Olainfarm for ?62.7 million.	CI
30/07/21	Janis Buks Elected as the Chairperson of the Management Board of JSC Olainfarm	CI
05/07/21	AS "AB CITY" made a mandatory bid to acquire 69.2% stake in AS Olainfarm for ?90.2 million.	CI
18/06/21	AS Olainfarm Approves Dividend for the Year 2020, Payable on July 12, 2021	CI
18/06/21	JSC Olainfarm Announces Board Appointments	CI
17/06/21	JSC Olainfarm Announces Management Changes	CI
17/06/21	JSC “Olainfarm” Elects Audit Committee	CI

07/01/22	Delisting of AS "Olainfarm” shares from the Baltic Main list	AQ
06/01/22	Notification about results of final buy-back of shares	AQ
30/12/21	Notification about final share buy-back	AQ
28/12/21	Correction: Regarding results of a share buy-back offer	AQ
28/12/21	On substantial participation (4) - specified	AQ

Manager	Title	Age	Since
Juris Hmelnickis CEO	Chief Executive Officer	46	01/01/2026
Janis Leimanis DFI	Director of Finance/CFO	56	-
Mikhail Skomorokhov CTO	Chief Tech/Sci/R&D Officer	-	01/01/2010

Director	Title	Age	Since
Andrejs Leibovics BRD	Director/Board Member	63	19/06/2021
Janis Buks CHM	Chairman	-	01/09/2022
Roberts Tavjevs BRD	Director/Board Member	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AS OLAINFARM	+7.19%	+2.67%	-	-	148M
ELI LILLY AND COMPANY	-0.61%	-3.43%	+36.07%	+115.04%	1,019B
JOHNSON & JOHNSON	-1.02%	-5.60%	+35.72%	+64.63%	617B
ABBVIE INC.	+1.11%	-0.58%	+12.36%	+77.95%	464B
MERCK & CO., INC.	+0.34%	-3.01%	+61.79%	+41.24%	356B
ROCHE HOLDING AG	+0.94%	-1.86%	+20.94%	+41.39%	333B
NOVARTIS AG	+1.07%	-3.03%	+11.27%	+34.95%	267B
ASTRAZENECA PLC	+0.24%	-4.66%	-6.41%	+9.25%	244B
AMGEN INC.	-1.04%	-2.79%	+35.30%	+51.84%	218B
GILEAD SCIENCES, INC.	-1.87%	-4.10%	+28.44%	+93.66%	179B
Average	+0.64%	-3.54%	+26.16%	+58.88%	410.8B
Weighted average by Cap.	-0.14%	-3.54%	+29.14%	+70.71%

AS Olainfarm Stock

Stocks

OLF1R

LV0000100501

Pharmaceuticals

Latest news: AS Olainfarm

Press Releases: AS Olainfarm

Quotes and Performance

Managers and Directors: AS Olainfarm

Latest insider transactions

Generic Pharmaceuticals

Company Profile